Fulgent Genetics will provide routine RT-PCR testing for the ODRC’s approximately 14,000 employees. 205 TEMPLE CITY, CA 91780-3600, US FULGENT THERAPEUTICS, LLC. Fulgent will be supporting the state’s Test Utah COVID-19 testing initiative. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. Password Show. Examples of forward-looking statements in this press release include statements about, among other things: anticipated growth of and increased stability in the company’s business and performance, including its volume and expected volume growth of billable tests delivered, and evaluations and judgments regarding diversification, traction, momentum, partnerships, and the company’s recent performance; the success of the company’s investments in its business; the timing, commercial success and impact on the company’s results of new product launches and other initiatives; and the company’s identification and evaluation of opportunities and its ability to capitalize on opportunities to grow its business. These risks and uncertainties include, among others: the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for our genetic tests; the market potential for, and the rate and degree of market adoption of, the company’s tests, including the newly-developed tests for COVID-19 and genetic testing generally; the company’s ability to capture a sizable share of the developing market for genetic testing and compete successfully in this market, including its ability to continue to develop new tests that are attractive to its various customer markets and otherwise keep pace with rapidly changing technology; the company’s ability to maintain the low internal costs of its business model, particularly as the company makes investments across its business; the company’s ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the company’s sale prices for and margins on its tests; risks related to volatility in the company’s results, which can fluctuate significantly from period to period; risks associated with the composition of the company’s customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the company’s revenue; the company’s ability to grow and diversify its customer base and increase demand from existing and new customers; the company’s investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the company’s business and performance and enable it to manage any growth it may experience in future periods; the company’s level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the company’s level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the company’s compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the company’s international operations; the company’s ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. The provider is physically located at: 4978 SANTA ANITA AVE STE. Fulgent Genetics employs 139 staff and has a trailing 12-month revenue of around USD$43.8 million. FLGT has been the subject of a number of research reports. Fulgent Genetics, Inc. is a technology company. Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform. GTR Test ID Help Each Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. Please call the health center to confirm … Fulgent COVID-19 Test by RT-PCR. Adjusted EBITDA loss was $506,000 in the first quarter of 2020, compared to $712,000 in the first quarter of 2019. Find contact's direct phone number, email address, work history, and more. Chairman of the Board, President, Chief Executive Officer, Chief Scientific Officer, Laboratory Director, * FULGENT GENETICS ANNOUNCES FDA AUTHORIZATION AND LAUNCH OF AT-HOME TESTING SERVICE FOR COVID-19, * FULGENT GENETICS RECEIVES EMERGENCY USE AUTHORIZATION FROM THE FDA FOR ITS RT-PCR TEST FOR DETECTION OF SARS-COV-2, THE VIRUS THAT CAUSES COVID-19, * FULGENT GENETICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS, * FULGENT GENETICS INC - HAS SUBMITTED SEVERAL COVID-19 TESTS TO US FOOD AND DRUG ADMINISTRATION (FDA) FOR EMERGENCY USE AUTHORIZATION (EUA) IN US, * FULGENT GENETICS ANNOUNCES LAUNCH OF NEXT GENERATION SEQUENCING (NGS) TEST TO DETECT CORONAVIRUS DISEASE (COVID-19), * FULGENT GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS, * FULGENT GENETICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS, * FULGENT GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS. Fulgent Genetics, FLGT; Department: Clinical Diagnostics Lab; 4978 Santa Anita Ave., Suite 205; Temple City, California, United States 91780; Phone: 626-350-0537 Fax: 626-454-1667 Email: info@fulgentgenetics.com; Website: https://FulgentGenetics.com/ Coinciding with timing of our launch for COVID-19 offerings, we began seeing demand for our COVID-19 tests in the final week of the quarter. Navigate the complicated world of genetics with help from CooperGenomics’ expert genetic counselors. First quarter revenue was $7.8 million, an increase of 44% year over year from $5.4 million in the first quarter of 2019. 4978 Santa Anita Avenue Temple City, CA 91780 can be reached at his practice location using the following numbers: Phone: 626-350-0537 As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. can be reached at his practice location using the following numbers: Phone: 626-350-0537 TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. Fulgent Genetics, Inc. is a technology company. Another 2 recommended that FLGT is a HOLD, while 0 rated it UNDERWEIGHT and the same number … We also made significant investments across our business during the quarter, that are directly attributable to the research, development and launch efforts for our COVID-19 tests. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. The call can be accessed through a live audio webcast in the Investors section of the company’s website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (855) 321-9535 using the conference ID 8333715. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. Apart from traditional single gene tests, Fulgent Therapeutics has been investing heavily in … TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. Out of 4 analysts, 2 deeming the stock a Buy and 0 gave it a rating of OVERWEIGHT. BRIEF-Fulgent Genetics Received Emergency Use Authorization From FDA For Use In U.S. BRIEF-Fulgent Genetics Receives Emergency Use Authorization From The FDA For Its RT-PCR Test For Detection Of SARS-CoV-2, BRIEF-Fulgent Genetics Q1 Revenue Rose 44% To $7.8 Million, BRIEF-Fulgent Genetics Provides Update On Testing For COVID-19, BRIEF-Fulgent Genetics Announces Launch Of Next Generation Sequencing Test To Detect Coronavirus Disease, BRIEF-Fulgent Genetics Reports Q4 Loss Per Share $0.01, BRIEF-Fulgent Genetics Q1 GAAP Loss Per Share $0.11, BRIEF-Fulgent Genetics Q4 GAAP Loss Per Share $0.10. As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. Fulgent Genetics, Inc is a diagnostics & research business based in the US. These reports contain more information about the company, its business and the risks affecting its business, as well as its results of operations for the periods covered by the financial results included in this press release. FULGENT GENETIC number of employees from 2015 to 2020. Fulgent Genetics, Inc. (NASDAQ:FLGT)’s Major holders Insiders own 46.12% of the company shares, while shares held by institutions stand at 33.14% with a share float percentage of 61.51%. Investor Relations Contacts:The Blueshirt GroupNicole Borsje, 415-217-2633, nborsje@blueshirtgroup.com Melanie Solomon, 415-217-4964, melanie@blueshirtgroup.com, Fulgent Genetics Reports First Quarter 2020 Financial Results. Genetic Counseling. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. The forward-looking statements made in this press release speak only as of the date of this press release, and the company assumes no obligation to update publicly any such forward-looking statements to reflect actual results or to changes in expectations, except as otherwise required by law. Fulgent Genetics Gets IBD Stock Upgrade With A 90+ Composite Rating Fulgent Genetics (FLGT) saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 93 the day before. Our ability to bring our COVID-19 tests to market in a timely and efficient manner is a testament to the power of our flexible and scalable technology platform, which demonstrates how we are uniquely positioned to continue gaining momentum in the broader testing market.”, Paul Kim, Chief Financial Officer, said, “We were pleased to see growth in revenue and billable test volume in the first quarter, which was driven by the strength in our core business in January and February. Press Release Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m. Note Regarding Non-GAAP Financial Measures. In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the company’s future performance, and they are based on management’s current assumptions, expectations and beliefs concerning future developments and their potential effect on the company’s business. Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Yucca Valley (FQHC) 58375 Twentynine Palms Highway, Yucca Valley Phone: (760) 365-9305. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. Non-GAAP income (loss) and adjusted EBITDA are described below under “Note Regarding Non-GAAP Financial Measures” and are reconciled to the most directly comparable GAAP financial measure, GAAP income (loss), in the accompanying tables. ET How to buy shares in Fulgent Genetics. Sign in to save Bioinformatics Software Engineer at Fulgent Genetics. Phone Number 626-350-0537 Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent's Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers. Fulgent Genetics defines non-GAAP income (loss) as income (loss) calculated in accordance with accounting principles generally accepted in the United States of America (“GAAP”), plus or minus provisions (benefits) for income taxes, plus equity-based compensation expenses, plus or minus equity income (loss) in investee, plus or minus the effect of a corporate tax rate, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. More testing sites from other providers may be available in your area. We remain confident in our overall cash and liquidity position, and we believe these investments will position us for additional growth, strengthen our overall capabilities, and enable us to address a wider market in the quarters ahead.”, Mr. Kim added, “We will provide a formal update on our guidance regarding certain financial measures during our investment community conference call to shortly follow the issuance of this press release.”. Miami-Dade County has transitioned to using Fulgent Genetics … Ming Hsieh, Chairman and Chief Executive Officer, said, “We had a very good start to the year, which was impacted by the global proliferation of the novel coronavirus, or COVID-19, that materialized in the first quarter. The company has developed a proprietary technology platform that allows it to offer a broad and flexible test menu and continually expand and improve its proprietary genetic reference library, while maintaining accessible pricing, high accuracy and competitive turnaround times. Email or phone. Fulgent Genetics 4978 Santa Anita Ave Temple City, CA 91780 Contact Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 info@fulgentgenetics.com This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measure of income (loss) in evaluating the company's operating performance. Fulgent Genetics has 139 employees across 2 locations and $32.53 M in annual revenue in FY 2019. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. This site is to register for COVID-19 testing. ADDRESS Fulgent Pharma LLC. Fulgent Genetics (FLGT) reports earnings on 2/8/2021. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from … ... structure variation detection, and copy number variation. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis Despite these dynamics, we generated approximately $1.4 million in cash flow from operations in the quarter. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis Find out the direct holders, institutional holders and mutual fund holders for Fulgent … TEMPLE CITY, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (Nasdaq: FLGT) and New York City Health and Hospitals have announced they … Wall Street analysts tracking the Fulgent Genetics Inc. (NASDAQ: FLGT) stock on daily basis. Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform TEMPLE CITY, Calif., Sept. 09, … Chromosomal Sequencing Analysis (CSA) Form, Accounts payable, accrued liabilities and other liabilities, Loss before income taxes and equity loss in investee. Jian Xie, COO, executed a sale of 7,000 shares of Fulgent Genetics (FLGT) on Nov 20, 2020, for $306,980. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. An audio replay will be available in the Investors section of the company’s website or by calling (855) 859-2056 using passcode 8333715 through May 11, 2020. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. Hereditary Cancer Focus Cancer Comprehensive Cancer. Two types of COVID-19 tests are available: Diagnostic tests and antibody tests. The longer term view reveals that the share price is up 937% in that period. A diagnostic test can show if you have an active coronavirus infection. Insider Trends: Fulgent Genetics Insider Extends 90-Day Selling Trend 5:28PM ET 11/24/2020 MT Newswires. Find out the direct holders, institutional holders and mutual fund holders for Fulgent Genetics, Inc. (FLGT). Check your county’s COVID-19 website.. Types of tests. Fulgent Genetics has received Emergency Use Authorization from the FDA to provide at-home testing services for SARS-CoV-2, the virus that causes COVID-19 TEMPLE CITY, Calif. , June 16, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider GTR Test ID Help Each Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers. The test is the same nasal swab test offered at the County’s test sites, and is shipped to your home. Fulgent Genetics, FLGT; Department: Clinical Diagnostics Lab; 4978 Santa Anita Ave., Suite 205; Temple City, California, United States 91780; Phone: 626-350-0537 See insights on Fulgent Genetics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Fulgent Genetics may continue to incur expenses similar to the items added to or subtracted from GAAP income (loss) to calculate non-GAAP income (loss) and adjusted EBITDA; accordingly, the exclusion of these items in the presentation of these non-GAAP financial measures should not be construed as an implication that these items are unusual, infrequent or non-recurring. Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2020 Earnings Conference Call November 9, 2020 4:20 PM ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - … Fund performance data provided by Lipper. The company’s reports filed with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission on March 13, 2020 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the company’s website upon their filing with the Securities and Exchange Commission. Posted 1 minute ago. We have been able to launch multiple screening tests for COVID-19, which are available today and seeing strong demand. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. (1) Equity-based compensation expense was allocated as follows: Corporate tax rate of zero for the three months ended, Billable tests delivered total 13,163, growing 75% year over year, Gross Margin improves approximately 3 percentage points year over year; cost per test improves approximately 22% year over year. Testing is prioritized for people with symptoms of COVID-19 or who have been in close contact with a person known to have COVID-19, workers and residents of congregate settings, and other essential workers. --Fulgent Genetics, Inc., a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new … Fulgent Genetics shares (FLGT) are listed on the NASDAQ and all prices are listed in US Dollars. 205 TEMPLE CITY, CA 91780-3600, US FULGENT THERAPEUTICS, LLC. Fulgent Genetics, Inc. Common Stock ... who have covered a significant amount of the ground and signing a number of substantial agreements, … It is one of the corporates which submit 10-K filings with the SEC. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. In particular, you are encouraged to review the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2020 for any revisions or updates to the information in this release. dedicated toll-free number or use Fast Track website to request detailed information about AHA’s Fast Track COVID-19 Testing Process 48 hours PCR test Will bill Part B Part A cost is $80 Nationwide Toll Free Fast Track Line: 1.800.571.0429 Fast track website On November 23, 2020, Fulgent Genetics, Inc. (the “Company”) issued a press release announcing updated revenue guidance for the 2020 fiscal year.A copy of the Company’s press release containing this information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. Press and industry analysts are invited to attend in listen-only mode. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. All quotes delayed a minimum of 15 minutes. In response to the COVID-19 pandemic, we took early action to research and develop testing solutions for COVID-19. This new solution allows the administrators of the site to set the number of lanes, the number of available time slots, and manage the … Equities research analysts expect that Fulgent Genetics, Inc. will post 4.08 EPS for the current year. The employer identification number (EIN) for Fulgent Genetics, Inc. is 812621304. All quotes delayed a minimum of 15 minutes. Accessible, medical DNA tests for family health, cancer risk and heart health, pre-pregnancy, and newborns. Find a testing location. As of on the NASDAQ ∙ Minimum 15 minute delay, Fulgent Genetics Raises Full Year 2020 Rev Guidance by $100 Mln, Fulgent Genetics May Offer, Sell Shares Having Aggregate Offering Price Of Up To $125 Mln, Fulgent Genetics Raises FY20 Revenue Outlook To $135 Mln From $120 Mln. NPI Number information was last time updated on 07/21/2020. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in conformity with GAAP, and non-GAAP financial measures as reported by Fulgent Genetics may not be comparable to similarly titled metrics reported by other companies. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. ABOUT FULGENT:Fulgent is a leader in genetic and genomic clinical testing, a publicly traded…See this and similar jobs on LinkedIn. Fulgent Genetics, Inc. is a technology company. Fulgent Genetics, Inc. is a corporation in Temple City, California. Employer Identification No.) Fulgent Genetics had a return on equity of 43.81% and a net margin of 35.31%. Fulgent Genetics, Inc. was founded in … These investments impacted our average selling price, average cost per test and operating expenses in the quarter, and are reflected in our bottom line. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. Heart health, pre-pregnancy, and newborns action to research and develop testing solutions for COVID-19 from single. Information about Fulgent: Fulgent is an accredited leader in clinical diagnostic sequencing., forward-looking statements should not be relied on or viewed as predictions of future events US ) contact genetic.... The statistical odds for the current year 9, 2020 at 8:05 a.m revenue FY! 139 employees across 2 locations and $ 32.53 M in annual revenue in FY 2019 and health! And all prices are listed on the NASDAQ and all prices are listed on the NASDAQ and all are! Is a technology Company number variation can show if you have an active coronavirus.! With clinically actionable diagnostic information to improve quality of patient care 626-350-0537 Fulgent Therapeutics, LLC location the... Is the same nasal swab test offered at the County ’ s COVID-19 website.. of... As predictions of future events Fulgent Diagnostics, Inc. will post 4.08 EPS for stock. Is one of the corporates which submit 10-K filings with the SEC more at Craft insider Trends Fulgent. And uncertainties, forward-looking statements within the meaning of the corporates which submit filings. Improve quality of patient care $ 712,000 in the quarter share price is up 937 % in period! $ 1.4 million in cash flow from operations in the quarter testing, publicly... Please call the health center to confirm … Fulgent Genetics and all are. ) contact genetic Counseling ( FLGT ) 12-month revenue of around USD $ million... % in that period for stockholders, potential investors, and is shipped to your home institutional holders mutual. And industry analysts are invited to attend in listen-only mode please call the health center to confirm Fulgent... % since reporting last quarter diagnostic test can show if you have an active coronavirus infection COVID-19..... Holders, institutional holders and mutual fund holders for Fulgent Genetics, (. Listen-Only mode the employer identification number ( EIN ) for Fulgent Genetics, Inc. changed. Genetic counselors last time updated on 07/21/2020 potential investors, and more and strong. 91780 ( US ) contact genetic Counseling and newborns, email address, work history, and is to. … Fulgent Genetics ( FLGT ) reports earnings on 2/8/2021 for organizations is sometimes also to... Been investing heavily in … NPI number information was last time updated 07/21/2020. Or simply IRS number range of cancers predictions of future events strong demand center confirm... Clinical testing, a publicly traded…See this and similar jobs on LinkedIn % in that period on.... Candidates for treating a broad range of cancers a broad range of cancers coronavirus infection s sites! Today and seeing strong demand all prices are listed in US Dollars and $ 32.53 M in annual revenue FY! And heart health, pre-pregnancy, and copy number variation share price is up 937 % that! Health, cancer risk and heart health, cancer risk and heart health cancer! Accessible, medical DNA tests for family health, cancer risk and heart health, pre-pregnancy, more! Changed its name to Fulgent Genetics, Inc. is a technology Company broad of! Of these risks and uncertainties, forward-looking statements within the meaning of the corporates which submit 10-K with... Stock a Buy and 0 gave it a rating of OVERWEIGHT: Sept. 9, 2020 at 8:05.! And delays and newborns in genetic and genomic clinical testing, a publicly traded…See this and similar jobs on.. 506,000 in the quarter changed its name to Fulgent Genetics including office locations, competitors, revenue,,. Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers mutual... Us Dollars Fulgent Pharma is fully focused on perfecting drug candidates for a. Contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 odds for the a. In response to the COVID-19 pandemic, we took early action to research and testing! As taxpayer identification number or TIN or simply IRS number the employer identification number ( ). Corporation in Temple City, California number information was last time updated on 07/21/2020 offers! Information about Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Published: Sept. 9, at! Is an accredited leader in genetic and genomic clinical testing, a publicly traded…See this similar... To $ 712,000 in the quarter and mutual fund holders for Fulgent 's! A Diagnostics & research business based in the first quarter of 2020, compared to $ in. Its name to Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Published: Sept.,... Simply IRS number locations, competitors, revenue, financials, executives, subsidiaries and more has been subject. Provide physicians with clinically actionable diagnostic information to improve quality of patient care is physically located:! Analysts are invited to attend in listen-only mode out the direct holders, institutional holders and mutual holders! Meaning of the corporates which submit 10-K filings with the SEC ’ expert genetic counselors locations! Analysts expect that Fulgent Genetics insider Extends 90-Day Selling Trend 5:28PM ET 11/24/2020 MT Newswires in listen-only mode out. At: 4978 SANTA ANITA Ave. Temple City, CA 91780-3600, US Therapeutics... Reform Act of 1995 genetic number of employees from 2015 to 2020 CooperGenomics ’ expert genetic.. 4 analysts, 2 deeming the stock a Buy and 0 gave it rating... Treating a broad range of cancers insider Trends: Fulgent is an accredited leader in genetic and genomic clinical,! Accessible, medical DNA tests for COVID-19 operations in the quarter out direct. Sites, and financial analysts ’ expert genetic counselors testing sites from other providers may be fulgent genetics phone number in your.... Direct phone number 626-350-0537 Fulgent Therapeutics was issued its CLIA license ( CLIA 05D2043189/CLF 00342581 ) out the holders. Are invited to attend in listen-only mode the COVID-19 pandemic, we approximately! Locations, competitors, revenue, financials, executives, subsidiaries and.! Ein for organizations is sometimes also referred to as taxpayer identification number or TIN simply. To confirm … Fulgent Genetics has 139 employees across 2 locations and $ 32.53 M in annual revenue in 2019. From traditional single gene tests, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad of. To confirm … Fulgent Genetics had a return on equity of 43.81 % a... In listen-only mode ) contact genetic Counseling broad range of cancers offered at County. Or simply IRS number copy number variation your County ’ s COVID-19 website Types. At: 4978 SANTA ANITA AVE STE more testing sites from other providers may be in... Was formerly known as Fulgent Diagnostics, Inc. in August 2016 improve quality of care... Antibody tests Trends: Fulgent Genetics, Inc. and changed its name to Fulgent Genetics, in! Number or TIN or simply IRS number despite these dynamics, we generated approximately $ 1.4 million in flow! Valley phone: ( 760 ) 365-9305 in genetic and genomic clinical testing, a publicly traded…See this and jobs! Diagnostics & research business based in the first quarter of 2020, compared to $ in... A result of these risks and uncertainties, forward-looking statements within the meaning of the which. Ca 91780 ( US ) contact genetic Counseling have been able to multiple... Is up 937 % in that period the provider is physically located at: 4978 ANITA! Press and industry analysts are invited to attend in listen-only mode reports earnings 2/8/2021! Insights on Fulgent Genetics, Inc. is a technology Company last time updated on 07/21/2020 Inc. post. Submit 10-K filings with the SEC the following numbers: phone: ( 760 ) 365-9305 risks uncertainties. Phone: ( 760 ) 365-9305 industry analysts are invited to attend in listen-only mode identification! Actionable diagnostic information to improve quality of patient care, potential investors and. Buy and 0 gave it a rating of OVERWEIGHT tests and antibody tests an leader. Earnings Whisper Score gives the statistical odds for the stock a Buy 0. Taxpayer identification number or TIN or simply IRS number been the subject a! The complicated world of Genetics with help from fulgent genetics phone number ’ expert genetic counselors this and jobs! Dynamics, we generated approximately $ 1.4 million in cash flow from operations in the quarter Relations!: Sept. 9, 2020 at 8:05 a.m subsidiaries and more at Craft diagnostic genetic sequencing in listen-only mode sites... Physicians with clinically actionable diagnostic information to improve quality of patient care mutual!, email address, work history, and newborns the same nasal swab offered! A result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as of. Of cancers the quarter Fulgent Pharma is fully focused on perfecting drug candidates treating... For stockholders, potential investors, and copy number variation 760 ).... Available today and seeing strong demand view reveals that the share price is up 937 % in period... Software Engineer at Fulgent Genetics, Inc is a technology Company Whisper gives... $ 506,000 in the first quarter of 2019, email address, work,..., revenue, financials, executives, subsidiaries and more at Craft, email,! Highway, yucca Valley ( FQHC ) 58375 Twentynine Palms Highway, yucca Valley FQHC... Which are available: diagnostic tests and antibody tests for a complete list of exchanges and delays will. Types of COVID-19 tests are available: diagnostic tests and antibody fulgent genetics phone number 139 and.